EXCLUSIVE | Even in the most respected of medical journals, pharmaceutical companies’ funding and other ties to studies open the door to bias.
November 24, 2012 - Washington Post
... The billions that the drug companies invest in such experiments help fund the world’s quest for cures. But their aim is not just public health. That money is also part of a high-risk quest for profits, and over the past decade corporate interference has repeatedly muddled the nation’s drug science, sometimes with potentially lethal consequences....
Your new post is loading...
